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Post-transcriptional modulation of inflammatory molecules is recently recognized for fine-tuning of 
inflammatory initiation and maintenance. In these molecules, some families with three cytosines and a histidine 
type of zinc finger domain are gaining attention. Among them, MCP-1 induced protein (MCPIP), also known 
as regulatory RNase 1 (Regnase-1), encoded by the Zc3h12a gene is recently recognized as a novel player for 
the inflammatory response. Meanwhile, the Transformed follicular lymphoma (TFL) gene is identified as a 
putative tumor suppressor gene for lung carcinoma, as well as malignant lymphoma. TFL is a member of the 
Zc3h12 gene family; hence, it is named as Zc3h12d. It has Nedd4-binding protein 1 and bacterial YacP-like 
protein domains, which resemble the N-terminus of PilT protein, acts as a ribonuclease, and degrades several 
cytokines similar to Regnase-1. TFL encodes mainly the 58Kda protein, p58TFL, which is expressed dominantly 
in lymphoid organs and is upregulated in activated T and B cells according to the inflammatory response. In 
contrast, MCPIP/Regnase-1 is expressed mainly in macrophages and for a short term in activated lymphocytes. 
TFL inhibits cell growth via upstream inhibition of the Rb signaling pathway like a tumor suppressor. 
Moreover, in contrast to other Zc3h12 family members, expression of TFL is increased slowly in activated 
lymphocytes, and inflammatory resolution is modulated, which is vital for tissue regeneration. Inflammatory 
dysregulation by TFL deficiencies brings about prolonged inflammation and may give rise to tumor 
susceptibility in lymphomagenesis. Therefore, TFL can be considered a novel regulatory marker of 
inflammation, as well as an indicator for tumor progression. 
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Introduction 
Post-transcriptional regulation is recently recognized as 
one of the crucial factors of inflammatory regulation [1]. 
Among them, mRNA regulation via 3’ untranslated region 
(3’UTR) is widely recognized. Recently, microRNAs 
(miRNAs) are thought to play crucial roles in the patho-
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genesis of some inflammatory diseases [2,3]. In cooperation 
with miRNA, RNA-binding protein (RBP) is an important 
player for the regulation of post-transcriptional pathway. 
Tristetraproline (TTP) is one of the well described 
molecules which recognizes AU-rich element of 3’UTR 
(ARE) and regulates several molecules, including 
cytokines and cyclooxygenase [4,5]. TTP deficiencies lead to 
inflammatory instability and cause some inflammatory 
diseases, such as rheumatoid arthritis, in TTP-deficient 
model mice[5]. TTP has tandem zinc finger motifs, which 
consist of three cytosines and a histidine (C3h). This motif 
is thought to be a RNA-binding motif, so molecules that 
possess this motif are predicted to bind some RNA and are 
related to post-transcriptional regulation. Among these 
molecules, the Zc3h12 family proteins have recently 
gathered great attention. MCP1-induced protein (MCPIP), 
which is encoded by Zc3h12a, is first reported as a 
“transcription factor-like” protein in macrophages being 
stimulated by MCP1[6]. Thereafter, the putative amino acid 
sequences of mouse and human Zc3h12a are shown for the 
conserved N-terminal domain to share a remote homology 
to the PilT N-terminus (PIN) domain for the degradation of 
several cytokine mRNAs, such as IL-6 and IL-12[7]. Since 
the RNase activity is strictly regulated in certain situations, 
such as inflammation, the Zc3h12a gene product is also 
designated as regulatory RNase-1 (Regnase-1) [8]. The role 
of MCPIP/Regnase-1 in immunology has been studied 
extensively. According to human genome analysis, there 
are four family genes, including Zc3h12a, 12b, 12c, and 
12d (Fig.1). In contrast to Zc3h12a, Zc3h12d is first 
reported as a putative tumor suppressor gene, namely as 
p34 for lung cancer [9] and as TFL for malignant 
lymphoma[10]. Thereafter, the gene product, p58TFL, has 
been expressed dominantly in several immune cells. 
Unfortunately, there is less information about the 
functional roles of Zc3h12b and 12c. In this review, we 
focus on TFL and the functional roles of p58TFL in the 
immune system. 
Identification of p58TFL in immune cells 
The TFL gene is mapped in human chromosome 6q25. 
The TFL is first reported as p34 by the study on loss of 
heterozygosity for familial lung cancer gene[9]. This gene 
has an A/G non-synonymous single nucleotide 
polymorphism (SNP) at codon 106, which alters the amino 
acid from lysine to arginine. Although this mutated p34 has 
some growth inhibition potency for xenograft mouse model, 
it has no significant association with familial lung cancer. 
In contrast, TFL is discovered by identification of a break 
point of the translocation site in “transformed follicular 
lymphoma” [11]. During transformation to diffuse large B 
cell lymphoma, the lymphoma cells have acquired an 
additional cytogenetic abnormality, t(2;6)(p12;q25), which 
suggests the translocation of the Immunoglobulin light 
chain kappa gene (Ig) to chromosome 6 long arm (6q). 
Chromosome 6q is widely known to include several tumor 
suppressor genes, such as A20 and EPHA7 [12, 13].  The 
translocation of TFL to Ig (head to head) leads to deletion 
of its translation initiation codon, ATG, and probably 
causes the loss of TFL function [10]. Interestingly, other 
family genes are also located frequently in the 
chromosomal deletion sites of cancer patients. Therefore, it 
is of interest whether these also act as putative tumor 
suppressors or not. 
Expression and cell growth inhibition 
The expression of TFL is dominant in the spleen and 
thymus but less in the bone marrow and brain. It i s  
Figure 1. TFL and its family members. The Zc3h12 family consists of four genes, namely Zc3h12a 
that encodes MCPIP/Regnase-1, Zc3h12b, Zc3h12c, and Zc3h12d that encodes TFL. The putative 
amino acid sequences have a common NYN (Nedd4-binding protein 1 and YacP-like nucleases) 
domain, which acts as RNase and regulates several cytokines or receptors in post-transcription. 
They also have the zinc finger motif, which consists of three cytosines and a histidine (C3h-Zn) and 
is considered as one of the RNA binding sites. They have different C-terminus motif, including a 
proline-rich motif, which is speculated to control the functional expression. 
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particularly prominent in the T and B cells rather than 
macrophages in the spleen. In human and mouse T and B 
cells, TFL expression is induced after immune activation in 
vivo, as well as in vitro. Introduction of TFL cDNA 
expression vector plasmids into some cell lines, such as 
Ba/F3 and Jurkat, leads to quick reduction of the cell 
proliferation[14]. Further analysis shows that TFL inhibits 
G1 to S entry of the cell cycle and Rb phosphorylation in 
normal mouse pre-B lymphocyte cell line, Ba/F3, as well 
as human lymphocytic leukemia cell line, Jurkat. 
Consistent with these results, T and B cells derived from 
TFL-deficient mice are facilitated in G1 to S progression of 
the cell cycle[15]. Therefore, TFL is thought to inhibit cell 
growth at least by upstream regulation of the Rb signaling 
pathway.   
TFL is first predicted to encode a 34Kda protein 
according to the putative amino acid sequences of p34 
cDNA. Later, TFL has been shown to produce dominantly 
a 58kda protein, p58TFL. The p34 mRNA/cDNA can be an 
alternatively spliced one, because a similar cDNA of which 
putative amino acid sequences predict the presence of 
p36TFL is also isolated independently. However, its 
physiological expression has not been confirmed, so far [14]. 
Introduction of p34 cDNA into a lung cancer cell line has 
been shown to inhibit its growth in vitro and tumor 
progression in vivo by using xenograft mouse model. 
Of note, the physiological expression of TFL in 
lymphocytes is upregulated according to cell activation and 
proliferation. The spatiotemporal expression of TFL in 
inflammatory tissues raises the possibility that TFL inhibits 
lymphocytic cell growth via a negative feedback system. 
Subcellular localization for post-transcriptional 
regulation 
The GFP-tagged p58TFL is expressed in the cytoplasmic 
granules where the mRNA processing body marker, DCP1a, 
co-localizes with one of the components of miRNA 
processing complex, AGO2[14]. Indeed, TFL co-localizes 
with a part, but not all of DCP1a-positive granules. In 
contrast, TFL does not overlap with a stress granule (SG) 
marker, TIA-1, but it localizes adjacent to p58TFL. For post-
transcriptional processing, the stress granules have a crucial 
role (Fig. 2). Transcribed mRNAs are not always translated 
into proteins. Some mRNAs are also stored temporarily in 
SGs under a stressful condition. They are released when 
needed for acute response; wherein, the time for expression 
is vital. As another crucial function of GW/P-bodies, 
nonsense-mediated mRNA decays to promote rapid 
degradation of aberrant mRNAs, such as transcripts 
including premature termination codon. These granules are 
functionally linked; hence, transient contacts are frequently 
observed[16]. Recently, GW/P-bodies are also highlighted in 
the field of precursor miRNA processing. Therefore, both 
transcriptional and post-transcriptional regulations are 
mutually affecting and controlling protein expression very 
precisely. Recently, another TFL family member, MCPIP 
has also been reported to localize with GW182 and partially 
with DCP1a[17,18]. Endogenous expression analysis of TFL 
localizes in most GW/P-bodies in THP-1 cells and activates 
Figure 2. Post-transcriptional regulation. The transcribed mRNA is transported to the subcellular 
polysomes to produce protein. When cellular stress or missense transcription of mRNA occurs, the 
transcribed mRNA is transported into the stress granules for tentative storage or into the 
GW/Processing bodies for degradation. GW/P bodies also play an important role of processing from 
precursor mRNA to mature RNA. The decapping enzyme, DCP1a, resides in the GW/P-bodies. 
Argonaute 2 (AGO2; also known as Eukaryotic translation initiation factor 2C, 2) in the GW/P bodies 
also functions as a processor from precursor microRNA to mature RNA. 
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human peripheral T cells. Based on all these observation, it 
is reasonable to consider that TFL, as well as MCPIP, is a 
component of GW/P-bodies[14-16]. Importantly, the 
cytoplasmic granules that express p58TFL are assembled 
after cell activation. Also, the deletion mutant of the C-
terminus domain of TFL, such as p36TFL, loses the 
subcellular localization at the cytoplasmic granules. It 
indicates that this domain is indispensable for the 
localization at GW/P-bodies, where TFL works in a 
restricted manner. 
RNase activity for several cytokine mRNAs 
The N-terminus of TFL has homology with those of 
other Zc3h12 family members. The PIN domain of 
Regnase-1 encoded by Zc3h12a acts as RNase, which 
results in mRNA degradation of cytokines, such as IL-2, 
IL-6, and IL-12[7]. Similarly, TFL is involved in the decay 
of several cytokine mRNAs, including IL-2, IL-6, IL-10, 
TNF, and IL-17a. Especially in IL-17a, TFL in CNS-
infiltrating CD4+ T cells acts as a cytokine regulator during 
the resolution phase of experimental autoimmune 
encephalitis (EAE) [15]. Of note, the expression of TFL is 
persistently elevated in CNS-infiltrating CD4+ T cells 
induced by MOG stimulation even during the resolution 
phase. Therefore, this negative feedback regulation by TFL 
seems to be indispensable for the resolution of cytokine 
storm induced by inflammation. The C3h type of zinc 
finger motif has an important role for binding at a specific 
site of 3’UTR of target transcripts, such as ARE. 
Deubiquitination activity 
A family member, MCPIP, is first reported to have a 
deubiquitinatio
cellular signaling[19]. TFL also seems to have the same 
activity that affects NFB signaling in the macrophage cell 
line, Raw 264.7[20]. In this study, a SNP variant of p36TFL 
with lysine at codon 106 instead of arginine has been shown 
to lose the DUB activity. However, in our recent study, 
there is no difference in the DUB activity between wild 
type and TFL-deficient lymphocytes harvested from the 
CNS, spleen, and lymph nodes during the resolution phase 
of EAE. Moreover, IL-17a-induced NFB signaling is not 
altered significantly in TFL-transfected HeLa cells[15]. 
Therefore, it is not yet determined how the DUB activity of 
TFL associates with its physiological function in vivo. 
 miRNA processing 
Another possible mechanism for inhibition of 
Figure 3. Regulation of inflammatory initiation & resolution via post-transcription pathway.  
Inflammation can be described into two phases, namely initiation and resolution. In the initiation 
phase, innate immunity, which is mainly governed by macrophages, plays an important role. 
Deregulation of this kind of inflammatory response causes severe inflammatory diseases, such as 
autoimmune and infectious diseases. For example, Tristetraproline (TTP)- deficient mice, in which 
TTP controls TNFa on macrophages, demonstrates rheumatoid arthritis-like phenotype. 
MCPIP/Regnase-1-deficient mice, in which MCPIP/Regnase-1 controls IL-6 on macrophages, 
demonstrates severe inflammation and cause early death. On the other hand, in the resolution 
phase, acquired immunity in which lymphocytes engage is overlapped. Therefore, immunity based 
on deregulatory lymphocytes has impact on inflammatory resolution. These kinds of deregulations 
provoke prolonged inflammation and may lead to irreversible tissue damage. Roquin regulates 
inducible costimulator (ICOS) on CD4+ T cell, and Roquin-deficient mice demonstrate lupus-like 
phenotype. TFL regulates IL-2 and IL-17a, which are produced by T cells, and TFL-deficient mice 
demonstrate prolonged inflammation on experimental autoimmune encephalopathy (EAE). 
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proliferation of inflammatory conditions is miRNA 
regulation via TFL. MCPIP has been reported to associate 
with miRNA biogenesis[18]. TTP interacts with miR-16 in 
the regulation of TNF[21]. TFL also recognizes the stem 
loop-like hairpin structure but not the ARE in 3’UTR of IL-
6 mRNA[15]. Moreover, some miRNAs, such as miR-195 
and let-7g, are downregulated in activated T cells derived 
from TFL-/- mice in comparison with those from wild-type 
mice (unpublished data). Since TFL, as well as MCPIP, 
localize in the GW/P bodies that exist in the RNA-induced 
silencing complex (RISC), miRNA maturation can be 
regulated by TFL also. It is interesting to examine if TFL is 
associated with miRNA processing. Inhibition of miRNAs 
by TFL may also contribute to the inhibition of some 
signaling of cell proliferation. 
Novel feedback mechanism in inflammation 
In the discussion of inflammation, we consider at least 
two distinctive phases; initiation and resolution phases (Fig. 
3). Both phases are tightly controlled by transcriptional and 
post-transcriptional factors[1]. In the initiation phase, innate 
immunity is more focused on the macrophage, which is the 
key player. For example, TTP controls TNF and IL-10 
expressions in the macrophage. The TTP-deficient mice 
demonstrate a rheumatoid arthritis-like phenotype. 
MCPIP/Regnase-1 also controls IL-6 mRNA expression 
and provokes plasma cell accumulation and early death. As 
regards the resolution phase, lymphocytes play vital roles 
in association with acquired immunity. Moreover, the focus 
is on post-transcriptional factors, which play a role on fine-
tuning of inflammatory control, since the resolution phase 
is important for the regeneration of damaged tissues. More 
damaged tissues require a smoother resolution. If the 
resolution phase is not efficient, tissue recovery will be 
impaired. Therefore, in some chronic inflammatory 
diseases, delayed or prolonged recovery may be inevitable. 
A RING-type ubiquitin ligase family member, Roquin, is 
discovered through the search for lupus-like severe 
autoimmune disease mouse model (san roque mice). It 
regulates an inducible costimulatory molecule, ICOS, via 
post-transcriptional pathway[22]. Previous study revealed 
that TFL-deficient mice showed prolonged inflammation 
when EAE was induced by MOG in spite of marginal 
difference at the initiation phase of encephalitis[15]. It 
means that TFL is one of the possible important post-
transcriptional regulators for inflammatory resolution. 
Thus, it is of interest whether TFL dysfunction may or may 
not be associated with human neuro-inflammatory diseases, 
such as multiple sclerosis. 
Interestingly, TNF-induced early response genes 
frequently possess ARE[23]. Therefore, the post-
transcriptional regulation of such early inducible genes is 
thought to be important for the regulation of inflammation. 
On the other hand, the functional role of mRNA regulation 
in T cells for the resolution of chronic inflammation is also 
thought to be important. However, the latter regulation 
seems to be overlooked, so far. If induced TFL in activated 
T cells has a functional role only for the resolution of 
chronic inflammation, it is reasonable to describe that the 
post-transcriptional machinery via TFL has little effect 
from induction to peak of disease not to dampen down the 
necessary inflammation. This function will in turn limit the 
expression of toxic inflammatory cytokines, such as IL-17a, 
during the resolution phase in order to inhibit excessive 
inflammation.  
Functional expression in spatiotemporal manner 
As shown above, TFL regulates several cytokine 
expressions in T cells, as well as B cells. In our EAE model, 
however, cytokine regulation via TFL is limited only 
within CNS-infiltrating lymphocytes even though TFL is 
activated in most peripheral immune organs, such as the 
spleen and lymph nodes. This is probably because post-
transcriptional regulation is subtle compared with the 
transcriptional effect. For example, TFL-deficient T cells 
secrete more IL-2 under anti-CD3 stimulation without a 
costimulatory signal compared with the wild type. 
However, the wild type T cells can secrete sufficient IL-2 
under anti-CD3 in the presence of co-stimulation with anti-
CD28. Alternatively, post-transcriptional regulation of the 
immune system can be restricted only to the inflammatory 
site. The EAE model using TFL-deficient mice has an 
impaired recovery from neuroinflammation due to the 
accumulation of Th17 cells in the spinal tissues. On the 
contrary, there is no accumulation of peripheral Th17 even 
though TFL in lymphocytes is fully upregulated but not 
activated. Moreover, this cannot be recapitulated in vitro 
merely under the Th17 skew condition, such as the addition 
of TGF- and IL-6 in the lymphocyte culture. Interestingly, 
there is no demonstration of more severe 
neuroinflammation in TFL-deficient than wild type mice 
during the initiation phase. Although there is enhanced 
paralysis in TFL-deficient mice at the peak of the disease, 
there is no increased accumulation of Th17 cells compared 
with the resolution phase. These results indicate that the 
role of TFL as a post-transcrptional regulator is more 
crucial for the resolution rather than initiation of 
inflammation. The regulatory mechanism of TFL has not 
been elucidated, so far. However, Regnase-1 is reported to 
be regulated via phosphorylation by IB kinase activity[8,24]. 
TTP is also reported to have similar regulation by mitogen-
activated protein kinase p38[25]. TFL can be regulated by 
such kinds of mechanisms, as well. In addition, since TFL 
has the same Malt-1/paracaspase cleavage site for Regnase-
1[24], it can also be regulated by the same enzymatic 
cleavage. 
Similarity and specificity of family members 
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The Zc3h12 family consists of four independent genes 
(Fig.1). The putative gene products have one conserved 
region in the middle, which includes a NYN domain and a 
C3h zinc finger motif. The N and C terminus of these 
molecules are divergent, and they probably define the 
specific function of each member. Moreover, each family 
member shows a specific pattern in its tissue expression. 
For example, the human brain expresses only Zc3h12b and 
Zc3h12c. On the contrary, the fetal liver expresses only 
Zc3h12a and Zc3h12d mRNAs. They are all inducible 
proteins, but the induction pattern is also different. In the 
macrophage cell line, Raw264.7, Zc3h12a and Zc3h12c 
mRNAs are quickly induced (about 2-4 hours after 
stimulation) and then return to basal level by 24 hours[26]. 
On the other hand, Zc3h12d mRNA is slowly induced after 
18 hours of stimulation in the macrophage. Even in T and 
B cells, induced p58TFL is expressed persistently at least 
until 72 hours after activation. Therefore, TFL is thought to 
be involved in the negative feedback loop to suppress 
excess inflammation.  
However, the spatiotemporal regulation of each family 
member in inflammation seems to be different. In the light 
of inflammatory initiation and resolution, TFL has a critical 
role for controlling inflammatory resolution rather than 
initiation. The ZC3h12 family seems to utilize its function 
to orchestrate the whole immune reaction. 
Future directions 
TFL is a novel post-transcriptional regulator for 
cytokine expression in immune reaction. Its deficiency 
induces some dysfunction in the resolution of inflammation. 
Post-transcriptional regulation has not been fully elucidated; 
however, more understanding of this type of regulator can 
lead to a discovery of a new molecular target that can be 
useful for clinical diagnosis, as well as treatment for 
inflammatory diseases. Moreover, since TFL is first 
reported as a tumor suppressor gene, it may be associated 
with lymphomagenesis via the dysregulation of NFB 
pathway in the lymphoma itself or lymphoma 
microenvironment where post-transcriptional regulation 
can also occur. The TFL study has just been started, but 
further studies can unveil the hidden pathway of immune 
regulation that governs not only autoimmune diseases but 
also many other inflammatory diseases. 
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